HERON THERAPEUTICS INC shareholders Q3 2023

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Washington Trust Advisors, Inc. 367$3790.00%
NATIONAL BANK OF CANADA /FI/ 600$5860.00%
ProShare Advisors LLC 13,453$13,8570.00%
BlackRock Inc. 8,126,849$8,370,6560.00%
CWM, LLC 450$00.00%
Bank of New York Mellon Corp 353,395$363,9970.00%
LPL Financial LLC 32,695$33,6760.00%
ENVESTNET ASSET MANAGEMENT INC 10,132$10,4360.00%
AdvisorNet Financial, Inc 110$1130.00%
Cambridge Investment Research Advisors, Inc. 15,617$160.00%
Citadel Advisors 11,300$11,6390.00%
Citadel Advisors 5,900$6,0770.00%
Citadel Advisors 10,390$10,7020.00%
Allspring Global Investments Holdings, LLC 41,034$42,2650.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 183,842$189,3570.00%
BENJAMIN EDWARDS INC 1,537$20.00%
HighTower Advisors, LLC 10,760$11,0000.00%
Raymond James Financial Services Advisors, Inc. 29,976$30,8750.00%
TWO SIGMA ADVISERS, LP 43,500$44,8050.00%
ArrowMark Colorado Holdings LLC 18,289$18,8380.00%
External links

This page lists HERON THERAPEUTICS INC's shareholders in Q3 2023. To view HERON THERAPEUTICS INC's shareholder history, click here.